Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM: Report of a case

Yoshiki Sawa, Shigeru Miyagawa, Taichi Sakaguchi, Tomoyuki Fujita, Akifumi Matsuyama, Atsuhiro Saito, Tatsuya Shimizu, Teruo Okano

研究成果: Article

215 引用 (Scopus)

抜粋

Dilated cardiomyopathy (DCM) is a heart muscle disease characterized by progressive heart failure, and is a leading cause of mortality and morbidity. Recently, cellular therapy for end-stage heart failure has been emerging. We herein report a 56-year-old male who received a transplant of autologous myoblast sheets manufactured in temperature-responsive culture dishes. His clinical condition improved markedly, leaving him without any arrhythmia and able to discontinue using a left ventricular assist system and avoid cardiac transplantation. These findings suggest that cellular therapy using myoblast sheets is a promising new strategy for treating patients with end-stage DCM. This method might be an effective alternative to heart transplantation in the near future.

元の言語English
ページ(範囲)181-184
ページ数4
ジャーナルSurgery Today
42
発行部数2
DOI
出版物ステータスPublished - 01-01-2012
外部発表Yes

All Science Journal Classification (ASJC) codes

  • Surgery

フィンガープリント Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM: Report of a case' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用